Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 02-Apr-24 4:59 PM View:  | Syros Pharmaceuticals, Inc. (SYRS) | 01-Apr-24 | Payment of Exercise | 14,052 | $5.12 | $71,946.20 | (10%) 145.71K to 131.66K | |
| 02-Apr-24 4:59 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 31-Mar-24 | Option Exercise | 45,566 | -- | -- | 46% 100.14K to 145.71K | |
| 15-Dec-23 6:46 PM View: | Seattle Genetics Inc. (SGEN) | 14-Dec-23 | Disposition | 62,753 | $229.00 | $14,370,400.00 | (100%) 62.75K to 0 | |
| 02-Nov-23 4:54 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 01-Nov-23 | Payment of Exercise | 13,401 | $2.22 | $29,750.20 | (12%) 113.55K to 100.14K | |
| 02-Nov-23 4:54 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 31-Oct-23 | Option Exercise | 40,125 | -- | -- | 55% 73.42K to 113.55K | |
| 02-Jun-23 6:20 PM View: | Seattle Genetics Inc. (SGEN) | 31-May-23 | Grant | 2,044 | -- | -- | 3% 62.75K to 64.8K | |
| 04-Apr-23 6:54 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 03-Apr-23 | Payment of Exercise | 1,852 | $2.58 | $4,778.16 | (2%) 75.27K to 73.42K | |
| 04-Apr-23 6:54 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 31-Mar-23 | Option Exercise | 6,000 | -- | -- | 9% 69.27K to 75.27K | |
| 14-Dec-22 5:49 PM View: | Seattle Genetics Inc. (SGEN) | 12-Dec-22 | Option Exercise | 8,750 | $36.70 | $321,125.00 | 16% 54.0K to 62.75K | |
| 17-May-22 7:28 PM View: | Seattle Genetics Inc. (SGEN) | 13-May-22 | Grant | 1,503 | -- | -- | 3% 52.5K to 54.0K | |
| 04-Apr-22 5:02 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 01-Apr-22 | Payment of Exercise | 58,883 | $1.12 | $65,949.00 | (8%) 751.61K to 692.72K | |
| 04-Mar-22 5:09 PM View: | Seattle Genetics Inc. (SGEN) | 02-Mar-22 | Option Exercise | 25,000 | $20.04 | $501,000.00 | 91% 27.5K to 52.5K | |
| 18-May-21 7:35 PM View: | Seattle Genetics Inc. (SGEN) | 14-May-21 | Grant | 1,402 | -- | -- | 5% 26.1K to 27.5K | |
| 21-Dec-20 4:58 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 18-Dec-20 | Option Exercise | 29,917 | $6.81 | $203,612.00 | 6% 533.69K to 563.61K | |
| 19-May-20 7:11 PM View: | Seattle Genetics Inc. (SGEN) | 15-May-20 | Grant | 1,335 | -- | -- | 5% 24.76K to 26.1K | |
| 23-Dec-19 4:54 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 23-Dec-19 | Option Exercise | 52,401 | $3.04 | $159,299.00 | 11% 481.29K to 533.69K | |
| 22-May-19 9:44 PM View: | Seattle Genetics Inc. (SGEN) | 20-May-19 | Grant | 2,963 | -- | -- | 14% 21.8K to 24.76K | |
| 14-Feb-19 5:19 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 12-Feb-19 | Grant | 188,000 | -- | -- | 39% 481.29K to 669.29K | |
| 03-Dec-18 4:06 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 29-Nov-18 | Option Exercise | 110,588 | $1.23 | $136,224.00 | 30% 370.7K to 481.29K | |
| 22-May-18 8:10 PM View: | Seattle Genetics Inc. (SGEN) | 18-May-18 | Grant | 3,700 | -- | -- | 20% 18.1K to 21.8K | |
| 23-May-17 7:22 PM View: | Seattle Genetics Inc. (SGEN) | 19-May-17 | Grant | 3,700 | -- | -- | 26% 14.4K to 18.1K | |
| 06-Jul-16 9:23 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 06-Jul-16 | Conversion | 66,666 | -- | -- | 14% 464.04K to 530.7K | |
| 24-May-16 8:15 PM View: | Seattle Genetics Inc. (SGEN) | 20-May-16 | Grant | 3,700 | -- | -- | 35% 10.7K to 14.4K | |
| 19-May-15 7:29 PM View: | Seattle Genetics Inc. (SGEN) | 15-May-15 | Grant | 3,700 | -- | -- | 53% 7.0K to 10.7K | |
| 20-May-14 7:55 PM View: | Seattle Genetics Inc. (SGEN) | 16-May-14 | Grant | 3,500 | -- | -- | 100% 3.5K to 7.0K | |
| 21-May-13 6:11 PM View: | Seattle Genetics Inc. (SGEN) | 17-May-13 | Grant | 3,500 | -- | -- | 100% 0 to 3.5K | |
| 15-May-08 3:24 PM View: | Millennium Pharmaceuticals ... (MLNMDD.PK) | 14-May-08 | Disposition | 77,410 | $25.00 | $1,935,250.00 | (100%) 77.41K to 0 | < 1% |
| 05-May-08 4:25 PM View: | Millennium Pharmaceuticals ... (MLNMDD.PK) | 01-May-08 | Market Sale (Planned) | 2,133 | $24.88 | $53,069.00 | (3%) 84.52K to 82.39K | < 1% |
| 07-Mar-08 4:18 PM View: | Millennium Pharmaceuticals ... (MLNMDD.PK) | 06-Mar-08 | Market Sale (Planned) | 11,729 | $13.25 | $155,409.00 | (13%) 91.94K to 80.21K | (88%) |
| 07-Mar-08 4:18 PM View: | Millennium Pharmaceuticals ... (MLNMDD.PK) | 05-Mar-08 | Market Sale (Planned) | 5,813 | $13.55 | $78,763.80 | (6%) 97.75K to 91.94K | (84%) |
| 04-Mar-08 10:10 AM View: | Millennium Pharmaceuticals ... (MLNMDD.PK) | 03-Mar-08 | Market Sale (Planned) | 3,150 | $13.99 | $44,068.50 | (3%) 100.9K to 97.75K | (78%) |
| 04-Mar-08 10:10 AM View: | Millennium Pharmaceuticals ... (MLNMDD.PK) | 29-Feb-08 | Market Sale (Planned) | 1,850 | $13.68 | $25,299.30 | (2%) 102.75K to 100.9K | (82%) |
| 19-Feb-08 4:27 PM View: | Millennium Pharmaceuticals ... (MLNMDD.PK) | 14-Feb-08 | Grant | 30,940 | -- | -- | 43% 71.81K to 102.75K | |
| 14-Dec-07 4:34 PM View: | Millennium Pharmaceuticals ... (MLNMDD.PK) | 13-Dec-07 | Option Exercise | 110,834 | $8.08 | $895,355.00 | 151% 73.49K to 184.32K | |
| 14-Dec-07 4:34 PM View: | Millennium Pharmaceuticals ... (MLNMDD.PK) | 13-Dec-07 | Market Option Sale | 110,834 | $15.44 | $1,711,350.00 | (60%) 184.32K to 73.49K | (62%) |
| 14-Dec-07 4:34 PM View: | Millennium Pharmaceuticals ... (MLNMDD.PK) | 13-Dec-07 | Market Sale | 2,229 | $15.44 | $34,417.30 | (3%) 73.49K to 71.26K | (62%) |